We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Liver Transplant Patients Show High Survival Rates

By HospiMedica staff writers
Posted on 12 Nov 2003
A study has found that more than 60% of liver transplant patients with advanced liver cancer are still alive after five years. More...
In contrast, the survival of patients who did not undergo transplant was nearly zero. The results were published in the October 28 online issue of the Journal of Clinical Oncology.

In addition to this high rate of survival, researchers found that survival rates had increased steadily over the last decade. This suggests that the criteria for patient selection established by other experts may help doctors select those patients most likely to respond well to the transplant. The investigators say that regular screening of patients with cirrhosis, a risk factor for cancer, is needed to detect cancer early and insure the best outcome.

The study involved 985 patients who had liver transplantation for liver cancer and more than 33,000 patients who had liver transplantation for other reasons. The researchers found significant and steady improvement in survival over time among the liver transplant patients with liver cancer. The five-year survival rate rose from 25.3% during 1987-1991, to 47% during 1992-1996, and to 61.1% during 1996-2001.

"This is good news for patients with liver cancer. If diagnosed early, transplantation is the treatment of choice for patients with liver cancer and advanced cirrhosis,” said lead author Paul Thuluvath, M.D., associate professor of medicine at Johns Hopkins Medical Institutions (Baltimore, MD, USA).




Related Links:
Johns Hopkins

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.